SCHEMBL7093526

SCHEMBL7093526

c1ccc(Cn2nc(-c3cccs3)c3sccc32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
ADORA1 P30542 4/20 0.49
ADORA2A P29274 4/20 0.47
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 3/20 0.44
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
GAA P10253 1/20 0.41
CYP2D6 P10635 1/20 0.41
CXCR2 P25025 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
USP2 O75604 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 1/20 0.40
CYP3A4 P08684 1/20 0.40
CASP1 P29466 1/20 0.40
RECQL P46063 1/20 0.40
CASP7 P55210 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094721 0.84 ADORA1 (0.50) KMT2AADORA1ADORA2AALDH1A1CYP1A2
SCHEMBL7094701 0.78 ESR1 (0.53) KMT2AADORA1ADORA2AALDH1A1KDM4E
SCHEMBL7096390 0.78 BTK (0.42) KMT2AADORA1ALDH1A1KDM4ECYP1A2
SCHEMBL7090320 0.78 ALDH1A1 (0.54) KMT2AADORA1ALDH1A1KDM4ECYP1A2
SCHEMBL6994778 0.76 ADORA1 (0.45) KMT2AADORA1ADORA2AALDH1A1CYP1A2
SCHEMBL13618712 0.76 PDE5A (0.66) KMT2AADORA1ADORA2AALDH1A1KDM4E
SCHEMBL7500320 0.74 PDE5A (0.46) KMT2AALDH1A1KDM4ECYP1A2CYP2C9
SCHEMBL2953485 0.74 PDE5A (0.67) KMT2AALDH1A1KDM4ECYP1A2CYP2C9
SCHEMBL13237887 0.74 PDE5A (0.53) KMT2AADORA1ADORA2AALDH1A1KDM4E
SCHEMBL7091163 0.74 F2RL3 (0.47) KMT2AADORA1ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed